Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-25 @ 4:16 AM
NCT ID:
NCT04979520
Eligibility Criteria:
Inclusion Criteria:
* Confirmed clinical diagnosis of Hidradenitis Suppurativa by the Principal Investigator
* Age 18 to 99 years old
* Moderate to severe Hidradenitis Suppurativa with draining tunnels (Hidradenitis Suppurativa Severity Score System/IHS4\>4)
* Must have medical insurance that is willing to pay for the study drug throughout the duration of the study
Exclusion Criteria:
* Inflammatory Bowel Disease
* HIV Positive
* Active Hepatitis B or C Infection
* Pregnant or Breastfeeding
* No concurrent use of any systemic antibiotics/retinoids/immunosuppressants/biologics (require washout period of \>5 half-lives)
* A Score of \>10 on the Beck's Depression Inventory (BDI) or on the Patient Health Questionnaire (PHQ)-9
* History of Keloid Scarring
* Any medical, psychological or social condition that, in the opinion of the Investigator, would jeopardize the health or well-being of the participant during any study procedures or the integrity of the data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04979520
Study Brief:
Protocol Section:
NCT04979520